Travere Therapeutics Inc at Jefferies Healthcare Conference Transcript
(audio in progress) Raycroft, and I'm one of the Biotech Analysts at Jefferies. It's with great pleasure that I'd like to welcome our guests today, Eric Dube, President and CEO of Travere, and Peter Heerma, the CCO of Travere. Thanks so much for joining us today.
Thanks for having us.
And we're going to do a fireside chat format. So maybe for those who are new to the story, if you could provide a one-minute intro [of future there]?
Sure. So Travere Therapeutics is a company based in San Diego, exclusively focused on rare disease. We have an established commercial portfolio and infrastructure that's been focused on rare kidney and liver disease for a number of years that we've now used really to establish what is in the early days of a successful launch of sparsentan or FILSPARI in IgA
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |